Endeavour Silver Corp.
EXK · NYSE
Analyst ratings
buy · 3 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 9, 2026 | HC Wainwright & Co. | Reiterates | Buy | $17.00 |
| May 7, 2026 | HC Wainwright & Co. | Reiterates | Buy | $17.00 |
| March 2, 2026 | HC Wainwright & Co. | Maintains | Buy | $17.00 |
| January 13, 2026 | B. Riley Securities | Maintains | Buy | $14.00 |
| January 9, 2026 | HC Wainwright & Co. | Reiterates | Buy | $14.50 |
| November 25, 2025 | HC Wainwright & Co. | Reiterates | Buy | $11.00 |
| November 13, 2025 | B. Riley Securities | Maintains | Buy | $11.00 |
| October 30, 2025 | HC Wainwright & Co. | Maintains | Buy | $11.00 |
| October 10, 2025 | CIBC | Maintains | Neutral | 14.00 |
| October 9, 2025 | HC Wainwright & Co. | Maintains | Buy | $9.75 |
Profitability and financial sustainability amid production growth
Revenue growth is projected to surge from $468M in 2025 to $614M in 2026, and Endeavour Silver beat Q1 2026 earnings estimates with $0.21 EPS versus $0.10 expected, signaling that strong production momentum and silver price tailwinds may finally translate into sustained profitability.
Despite impressive production figures — including 3.4 million silver equivalent ounces in Q2 2026 — the company continues to report negative net income margins, negative ROE, and persistent cash flow concerns, raising serious doubts about its ability to achieve durable profitability.
Stock valuation and analyst price target divergence
Analysts at MarketBeat cite an average 12-month price target of C$19.23, representing nearly 85% upside from current levels, with a high target of C$28.00 from top-rated analysts. CIBC and BMO Capital have both raised their targets significantly, with CIBC going as high as C$25.
Not all analysts share the optimism: the lowest 12-month price target sits at C$12.15, and TipRanks data shows a wide forecast range from C$9.81 to C$16.03, indicating deep disagreement over whether current valuation ratios are justified given the company's fundamentals.
Technical momentum versus near-term reversal risk
Technical indicators on both short- and long-term moving averages issue buy signals, with the short-term average trading above the long-term average. A strong rising trend suggests the stock could rise over 70% in the next three months, and MACD confirms the upward momentum.
A sell signal was triggered from a pivot top point in July 2025, and volume declined during recent price gains — a divergence that analysts flag as an early warning sign. The stock is trading closer to resistance than support, making the intraday risk/reward unattractive.